Shanghai Haoyuan Chemexpress Co., Ltd.

688131

CNE1000051J4

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-12 pm EDT			5-day change	1st Jan Change
32.67 ^CNY	-3.54%		-5.69%	-37.25%

Apr. 29	Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 25	Haoyuan Chemexpress to Issue 822 Million Yuan Worth of Convertible Bonds	MT

Shanghai Haoyuan Chemexpress Co., Ltd.(SHSE:688131) added to Shanghai Stock Exchange A Share Index

June 08, 2022 at 12:00 am EDT

Shanghai Haoyuan Chemexpress Co., Ltd has been added to Shanghai Stock Exchange A Share Index

Latest news about Shanghai Haoyuan Chemexpress Co., Ltd.

Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Haoyuan Chemexpress to Issue 822 Million Yuan Worth of Convertible Bonds	Mar. 25	MT
Haoyuan Chemexpress to Raise Subsidiary's Capital by 200 Million Yuan	Mar. 25	MT
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Shanghai Haoyuan Chemexpress Co., Ltd.(XSSC:688131) added to S&P Global BMI Index	23-09-18	CI
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Shanghai Haoyuan Chemexpress Shareholders Plan to Unload Company's Stakes	23-07-20	CI
Shanghai Haoyuan Chemexpress Co., Ltd.(SHSE:688131) dropped from Shanghai Stock Exchange Health Care Sector Index	23-06-09	CI
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Haoyuan Chemexpress to Build Drug Center for 500 Million Yuan	23-04-11	MT
Haoyuan Chemexpress Logs 1.4% Rise in 2022 Profit	23-02-28	MT
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-26	CI
Haoyuan Chemexpress Raising 50 Million Yuan From Controlling Shareholder to Buy Local Drugmaker	23-01-13	MT
Shanghai Haoyuan Chemexpress Co., Ltd. announced that it has received CNY 49.999962 million in funding from Shanghai Anxu Information Technology Co., Ltd., Shanghai Yuanmeng Enterprise Management Consulting Partnership (Limited Partnership), Ningbo Jiusheng Innovation Pharmaceutical Technology Co., Ltd, Shanghai Yuanli Enterprise Management Partnership	22-12-27	CI
Shanghai Haoyuan Chemexpress Co., Ltd. completed the acquisition of 2Y-Chem, Ltd. from Ningbo Jiusheng Innovative Pharmaceutical Technology Co., Ltd., Qidong Yuanli Enterprise Management Consulting Partnership (Limited Partnership), Shanghai Yuanmeng Enterprise Management Consulting Partnership (Limited Partnership) and WANG YUAN.	22-12-23	CI
Shanghai Haoyuan Chemexpress Co., Ltd.(SHSE:688131) added to Shanghai Stock Exchange Health Care Sector Index	22-12-12	CI
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Shanghai Haoyuan Chemexpress Co., Ltd.(SHSE:688131) added to Shanghai Stock Exchange A Share Index	22-06-08	CI
Shanghai Haoyuan Chemexpress Co., Ltd.(SHSE:688131) added to Shanghai Stock Exchange Composite Index	22-06-08	CI
Certain A Shares of Shanghai Haoyuan Chemexpress Co., Ltd. are subject to a Lock-Up Agreement Ending on 8-JUN-2022.	22-06-07	CI
Shanghai Haoyuan Chemexpress Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Shanghai Haoyuan Chemexpress Co., Ltd. agreed to acquire 2Y-Chem, Ltd. from Ningbo Jiusheng Innovative Pharmaceutical Technology Co., Ltd., Qidong Yuanli Enterprise Management Consulting Partnership (Limited Partnership), Shanghai Yuanmeng Enterprise Management Consulting Partnership (Limited Partnership) and WANG YUAN for CNY 410 million.	22-03-04	CI
Haoyuan Chemexpress Posts 48% Profit Jump in 2021 on Strong Drug Development Demand	22-02-25	MT

Chart Shanghai Haoyuan Chemexpress Co., Ltd.

Duration

Period

Chart Shanghai Haoyuan Chemexpress Co., Ltd.

More charts

Shanghai Haoyuan Chemexpress Co Ltd is a China-based company mainly engaged in the research and development, production and sales of small molecule drugs. The Company's main products include molecular building blocks and tool compounds. The Company's products also include active pharmaceutical ingredients (APIs) and intermediates. The Company also provides related services such as contract research organization (CRO) service. The Company's molecular building blocks and tool compounds are applied in all stages of the drug discovery process. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Shanghai Haoyuan Chemexpress Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

32.67

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
SHANGHAI HAOYUAN CHEMEXPRESS CO., LTD.	-37.25%	679M
CSL LIMITED	-2.47%	89.37B
SAMSUNG BIOLOGICS CO.,LTD.	+2.76%	40.65B
BIOGEN INC.	-12.97%	32.81B
UCB	+51.90%	25B
BIOMARIN PHARMACEUTICAL INC.	-16.70%	15.29B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42.60%	11.61B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.82%	11.49B
SWEDISH ORPHAN BIOVITRUM AB	+5.62%	8.98B
INNOVENT BIOLOGICS, INC.	-7.72%	8.23B

Biopharmaceuticals